Davidmcmahon
@drdavidmcmahon.bsky.social
🇮🇪 Medical Oncologist
Post CSCST research fellow in thoracic oncology @ Royal Marsden Hospital
Arsenal fan (for my sins)
Post CSCST research fellow in thoracic oncology @ Royal Marsden Hospital
Arsenal fan (for my sins)
with that in mind, how uniform is the approach at top clubs regarding injury prevention? i imagine the management of the damage and road to recovery is very similar across the spectrum.
September 4, 2025 at 8:11 AM
with that in mind, how uniform is the approach at top clubs regarding injury prevention? i imagine the management of the damage and road to recovery is very similar across the spectrum.
Given how subspecialised medicine is now, I seriously doubt the management of injuries is much different at Arsenal compared to any other top flight club. e.g I'm certain the players who had hamstring surgery last year all went to an orthopedic surgeon with a special interest in hamstrings. 1/2
September 4, 2025 at 8:09 AM
Given how subspecialised medicine is now, I seriously doubt the management of injuries is much different at Arsenal compared to any other top flight club. e.g I'm certain the players who had hamstring surgery last year all went to an orthopedic surgeon with a special interest in hamstrings. 1/2
- Neoadjuvant and adjuvant landscape
- Pregnancy and family planning
- Long term follow up, and the differences between the adjuvant and metastatic settings (can we de-intensify?)
- Management of brain metastases
- Evolving landscape of cellular therapeutics and individualised neoantigen therapies
- Pregnancy and family planning
- Long term follow up, and the differences between the adjuvant and metastatic settings (can we de-intensify?)
- Management of brain metastases
- Evolving landscape of cellular therapeutics and individualised neoantigen therapies
February 6, 2025 at 8:33 PM
- Neoadjuvant and adjuvant landscape
- Pregnancy and family planning
- Long term follow up, and the differences between the adjuvant and metastatic settings (can we de-intensify?)
- Management of brain metastases
- Evolving landscape of cellular therapeutics and individualised neoantigen therapies
- Pregnancy and family planning
- Long term follow up, and the differences between the adjuvant and metastatic settings (can we de-intensify?)
- Management of brain metastases
- Evolving landscape of cellular therapeutics and individualised neoantigen therapies
@dralexiusjohn.bsky.social nice data. more 0% pCR... await neoadaura
December 26, 2024 at 1:21 PM
@dralexiusjohn.bsky.social nice data. more 0% pCR... await neoadaura